For example, CRISPR-mediated knockdown of FZD7 has reduced Wnt/β-catenin signaling in preclinical colorectal cancer models, highlighting the potential for gene-editing approaches in targeting FZD-driven oncogenesis (Hu et al., 2023). The gene discussed is FZD7; the disease is colorectal cancer.